Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Joachim

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
BMC Pulmonary Medicine|May 1, 2013
High-sensitive Troponin T increase after exercise in patients with pulmonary arterial hypertensionMirko Völkers, David Rohde, Thomas Zelniker, et al.
European Journal of Clinical Investigation|April 17, 2012
Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertensionMark Rosenberg, F Joachim Meyer, Ekkehard Gruenig, et al.
Journal of Neurosurgery|March 1, 1980
Tuberculous brain abscess. Case reportP R González, C V Herrero, G F Joachim, et al.
Pharmacy World & Science : PWS|August 10, 2010
A purging procedure for pantoprazole and 4-lumen catheters to prevent IV drug incompatibilitiesThilo Bertsche, Carolin Veith, Alexander Stahl, et al.
International Journal of Cardiology|May 7, 2010
Respiratory muscle dysfunction in congestive heart failure--the role of pulmonary hypertensionArthur Filusch, Ralf Ewert, Maike Altesellmeier, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 29, 2009
Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatmentLutz Frankenstein, Manfred Nelles, F Joachim Meyer, et al.
Respiratory Medicine|August 11, 2007
Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertensionRalf Bauer, Christoph Dehnert, Palma Schoene, et al.
International Journal of Cardiology|January 24, 2012
Osteopontin (OPN) improves risk stratification in pulmonary hypertension (PH)Mark Rosenberg, F Joachim Meyer, Ekkehard Gruenig, et al.
Respiratory Research|January 1, 2010
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertensionAnnette S Droste, David Rohde, Mirko Voelkers, et al.
Journal of Clinical Pharmacology|September 17, 2009
Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 studyEkkehard Gruenig, Evangelos Michelakis, Jean-Luc Vachiéry, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
BMC Pulmonary Medicine|May 1, 2013
High-sensitive Troponin T increase after exercise in patients with pulmonary arterial hypertensionMirko Völkers, David Rohde, Thomas Zelniker, et al.
European Journal of Clinical Investigation|April 17, 2012
Osteopontin predicts adverse right ventricular remodelling and dysfunction in pulmonary hypertensionMark Rosenberg, F Joachim Meyer, Ekkehard Gruenig, et al.
Journal of Neurosurgery|March 1, 1980
Tuberculous brain abscess. Case reportP R González, C V Herrero, G F Joachim, et al.
Pharmacy World & Science : PWS|August 10, 2010
A purging procedure for pantoprazole and 4-lumen catheters to prevent IV drug incompatibilitiesThilo Bertsche, Carolin Veith, Alexander Stahl, et al.
International Journal of Cardiology|May 7, 2010
Respiratory muscle dysfunction in congestive heart failure--the role of pulmonary hypertensionArthur Filusch, Ralf Ewert, Maike Altesellmeier, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 29, 2009
Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatmentLutz Frankenstein, Manfred Nelles, F Joachim Meyer, et al.
Respiratory Medicine|August 11, 2007
Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertensionRalf Bauer, Christoph Dehnert, Palma Schoene, et al.
International Journal of Cardiology|January 24, 2012
Osteopontin (OPN) improves risk stratification in pulmonary hypertension (PH)Mark Rosenberg, F Joachim Meyer, Ekkehard Gruenig, et al.
Respiratory Research|January 1, 2010
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertensionAnnette S Droste, David Rohde, Mirko Voelkers, et al.
Journal of Clinical Pharmacology|September 17, 2009
Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 studyEkkehard Gruenig, Evangelos Michelakis, Jean-Luc Vachiéry, et al.
Pageof 6